Navigation Links
Biomarkers Market: Epigenetic & MicroRNA Biomarkers Report
Date:8/16/2013

DALLAS, Aug. 16, 2013 /PRNewswire-iReach/ -- The epigenetic and microRNA biomarkers fields are co-evolving and have reached a critical point wherein enough signatures have been identified across various different disease classes, most notably in cancer, that some of these signatures/expression patterns can be validated and deployed for use in the clinic.  However, these biomarker fields are evolving in parallel with the research marketplace, and this market report characterizes the research markets for both these fields so as to present a comprehensive analysis that en bloc provides a complete picture of this expanding marketplace.

(Photo: http://photos.prnewswire.com/prnh/20130816/MN65209)

The Epigenetic and MicroRNA Biomarkers 2013 Market Report

(http://www.reportsnreports.com/reports/267365-epigenetic-and-microrna-biomarkers-2013-market-report.html ) is written in PowerPoint and is delivered to customers in this format enabling convenient drag-and-drop into R&D Presentations, Business Plans, Investor Presentations.  Associated files that constitute the complete report package are in Excel and PDF formats.

Specific Topics Addressed in this Market Report:

  • Epigenetics Research Market Analysis
    • Primary Market Survey to Characterize Research Market Trends based on Data Collected from Researchers
    • Breakout of Epigenetics Research Activity based on Epigenetic Modifications Studied
    • Segmentation of Epigenetics Research Activity based on Disease Classes Studied
    • Epigenetics Research Activity in Cancer--Quantitative Segmentation
    • Reagent Kits and Products in the Epigenetics Research Field [Details of Products from the Vendors in this Space are Presented and Analyzed]
  • Epigenetics Biomarkers
  • En masse Analysis of All Epigenetics-focused Publications and Trends from these Data with respect to Potential Epigenetics Biomarkers
  • Description of Epigenetic Biomarkers Identified to Date in Various Cancer Classes [Nature of Epigenetic Signature, Potential Role in Prognostics and Diagnostics]
  • Primary Market Survey Data Presents a Complete Picture of the microRNA Research Field based on End-User/Researcher Practices
  • Methodologies and Market Breakout for Expression Profiling
  • Quantitative Breakout of the microRNA Research Market Across the Research Workflow
  • Product Vendors and their Quantitative Penetrance in the microRNA Research Markets
  • Expression Patterns/Signatures of microRNAs in Different Disease States
  • Prognostic/Diagnostic Potential of microRNA Expression Patterns
  • microRNAs in Biological Fluids as Circulating Biomarkers: List and Significance
  • Traditional Cancer Biomarkers
  • Oncogenes
  • Tumor-Suppressor Genes
  • Up-to-date List of CDx on the Marketplace
  • Partnerships in the CDx Space
  • MicroRNA Research Market Analysis
  • MicroRNA Biomarkers Analysis
  • Cancer Biomarker Classes
  • Companion Diagnostics (CDx)

Buy a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=267365 .

Table of Contents for the Epigenetic and MicroRNA Biomarkers 2013 Market Report:

Chapter I. Epigenetics Research Market Analysis
Primary market survey to Characterize Marketplace from the
Bottom-up: Qualitative and Qualitative Market Data
Current Research Paradigms
Quantitative Segmentation of Epigenetics Research
Epigenetics research in Cancer: Quantitative Segmentation
Commercial kit and Reagent offering in the Epigenetics Research Marketplace

Chapter II. Epigenetic Signature as Potential Biomarkers
Big Data Analysis of Epigenetics Publication Landscapes
Hotspot Analysis of Publications Describes Segments of Opportunity vis-a-vis Research Product Development as well Potential Assay Development for Disease Associations, Harvesting of Prognostic as well as Diagnostic Biomarkers
Epigenetic Signatures Described in Various Disease Classes
DNA Methylation as Disease Biomarkers
Histone Modification as Disease Biomarkers
Potential Epigenetic Biomarkers in Various Cancer Classes
Gastric Cancer
Pancreatic Cancer
Prostate Cancer

Chapter III. micrRNA Research Market Analysis microRNA Signatures as Potential Biomarkers
Primary Market Survey to Characterize Marketplace from the Bottom-Up: Quantitative and Quantitative Market Data
microRNA Research vis-à-vis Content Classes
microRNA Research in Cancer
microRNA Research Workflow: Quantitative Breakout
microRNA Expression Profiling Quantitative market breakout
microRNA Vendor Market Penetration Space Map
NGS to study micrRNAs-Market Breakout by Platform
Unmet Needs in the microRNA Research Space
microRNA Signatures Describes in Various Disease Classes: Potential for Biomarkers Development
Tumor Suppressor microRNA Methylatoin
microRNA in Biofluids
Circulating microRNAs as Potential Tumor Markers

Chapter IV. Characterization of Molecular Biomarker Classes
Traditional Cancer Biomarkers
Oncogenes
Tumor Suppressor Genes

Appendix I. Epigenetics and MicroRNA Biomarkers Summary

Appendix II. List of Companion Diagnostics (Cdx) on the Market, In Progress Cdx in Development/Partnership, Potential Market Size for Epigenetics and microRNA-based CDx

Appendix III. Research Methodology

Complete report available at http://www.reportsnreports.com/reports/267365-epigenetic-and-microrna-biomarkers-2013-market-report.html .

You may also be interested in other reports we have biomarkers:

PharmaFocus: Biomarkers in Alzheimer's Disease at http://www.reportsnreports.com/reports/264710-pharmafocus-biomarkers-in-alzheimers-disease.html .

Biomarker Partnering Terms and Agreements at http://www.reportsnreports.com/reports/56447-biomarker-partnering-terms-and-agreements.html .

Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017 at http://www.reportsnreports.com/reports/214354-metabolomics-biomarker-discovery-metabolite-detection-metabolite-profiling-market-by-applications-drug-discovery-toxicology-assessment-diagnosis-and-indications-oncology-cardiology-neurology-forecasts-from-2012-to-2017.html .

Explore all reports on biomarkers market at http://www.reportsnreports.com/tags/biomarker-market-research.html .

About Us:

ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. Call +1 888 391 5441 with your research requirements.

Media Contact: Priyank Tiwari, ReportsnReports.com, +1 888 391 5441, sales@reportsandreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE RnRMarketResearch.com
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
2. Trial seeks improved lung-cancer screening by combining imaging and biomarkers
3. Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease
4. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
5. VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2013
6. Spanish researchers design biomarkers for the detection of dengue and West Nile virus
7. NIH funds research to identify Parkinsons biomarkers
8. New AAN/ALS Association Clinical Fellow Will Pursue Immune Biomarkers
9. Epigenetic biomarkers may predict if a specific diet and exercise regimen will work
10. Novel biomarkers improve diagnosis in rheumatoid arthritis
11. hESC Products Market: Human Embryonic Stem Cell Patent IP Landscape Opportunity Analysis in New Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... 2017  SomaLogic announced today that it has ... by iCarbonX, the China -based ... Digital Health Ecosystem that can define each person,s ... biological, behavioral and psychological data, the Internet and ... SomaLogic will provide proteomics data and applications expertise ...
(Date:1/4/2017)... , Jan. 4, 2017  For the thousands of attendees at ... global leader in connected health and biometric measurement devices and services, will ... On display in A&D Medical,s special CES Exhibit Suite ... the ongoing expansion of the company,s WellnessConnected product platform.  ... ...
(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... ... January 20, 2017 , ... SpineFrontier, ... next evolution in spinal fusion, the MISquito Percutaneous Pedicle Screw System (part ... SpineFrontier is focused on technique driven product solutions that provide maximum efficiency ...
(Date:1/19/2017)... Jan 19, 2017 Research and Markets ... has announced the addition of the ... - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market ... 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... -- AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), a ... a majority-owned subsidiary of Intrexon Corporation (NYSE: ... of its common shares on the NASDAQ Stock Market ... "AquaBounty,s listing on NASDAQ represents an important milestone for ... U.S. markets as we advance plans for commercial production ...
(Date:1/19/2017)... , Jan. 18, 2017 The ... reach USD 92.9 billion by 2025, according to ... Pharmaceutical industry has been adaptive of the function ... early as 2002. Among the services outsourced, clinical ... For instance, Johnson & Johnson was the first ...
Breaking Biology Technology: